Φορτώνει......
Mechanisms of failure of chimeric antigen receptor T-cell therapy
Although chimeric antigen receptor T (CART)-cell therapy is best recognized for its antitumor effect in relapsed/refractory B-cell hematological cancers, it is still associated with a high relapse rate. RECENT FINDINGS: We firstly analyzed internal immunological and genetic reasons of CD19+ relapse...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Opin Hematol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams And Wilkins
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791516/ https://ncbi.nlm.nih.gov/pubmed/31577606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0000000000000548 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|